Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | LDHB | P07195 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | F7 | P08709 | 1/20 | 0.35 |
| ▸ | F3 | P13726 | 1/20 | 0.35 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.35 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.35 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.35 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamic Acid SCHEMBL7251118 | 1.00 | ACHE (0.54) | ACHEHCAR2LDHALDHBTDP1 | |
| Carbamic Acid SCHEMBL8573342 | 1.00 | ACHE (0.54) | ACHEHCAR2LDHALDHBTDP1 | |
| Carbamic Acid SCHEMBL4048026 | 1.00 | ACHE (0.54) | ACHEHCAR2LDHALDHBTDP1 | |
| Urea SCHEMBL2538456 | 0.88 | LMNA (0.50) | ACHEHCAR2LDHALDHBTDP1 | |
| Urea SCHEMBL5146646 | 0.88 | LMNA (0.50) | ACHEHCAR2LDHALDHBTDP1 | |
| Bicarbonate SCHEMBL27606044 | 0.84 | HCAR2 (0.47) | HCAR2NAPRTBCAT2 | |
| Bicarbonate SCHEMBL3158090 | 0.84 | HCAR2 (0.47) | HCAR2NAPRTBCAT2 | |
| Pyrimidine SCHEMBL28643613 | 0.83 | F7 (0.46) | ACHEHCAR2TDP1ALDH1A1F7 | |
| Pyrimidine SCHEMBL1150634 | 0.83 | F7 (0.46) | ACHEHCAR2TDP1ALDH1A1F7 | |
| Pyrimidine SCHEMBL27627207 | 0.81 | F7 (0.44) | ACHEHCAR2TDP1ALDH1A1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214949-A1 | TRIAZINE CARBAMATE CROSSLINKER | ALLNEX USA INC. (US) | 2025-07-03 | — | — | US | claimed |
| EP-4532211-A1 | TRIAZINE CARBAMATE CROSSLINKER | Allnex USA Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| CN-119255916-A | Triazine carbamate cross-linking agents | 湛新美国股份有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-118829067-A | Laminate, method for producing same, and use of laminate | DIC株式会社 | 2024-10-22 | — | — | CN | claimed |
| WO-2023230122-A1 | TRIAZINE CARBAMATE CROSSLINKER | ALLNEX USA INC. (US) | 2023-11-30 | — | — | WO | claimed |
| EP-4282859-A1 | TRIAZINE CARBAMATE CROSSLINKER | Allnex USA Inc. (US) | 2023-11-29 | — | — | EP | claimed |
| CN-107074786-B | Process for preparing triazine carbamates | 湛新荷兰有限公司 | 2020-09-22 | — | — | CN | claimed |
| EP-3191460-B1 | PROCESS FOR THE PREPARATION OF TRIAZINE CARBAMATES | ALLNEX NETHERLANDS BV (NL) | 2020-01-29 | — | — | EP | claimed |
| CN-105026377-B | Process for preparing triazine carbamates | 湛新荷兰有限公司 | 2019-08-16 | — | — | CN | claimed |
| EP-3517530-A1 | PROCESS FOR THE PREPARATION OF TRIAZINE CARBAMATES | Allnex Netherlands B.V. (NL) | 2019-07-31 | — | — | EP | claimed |
| US-20050249879-A1 | Packaging coating containing 1,3,5-triazine carbamate crosslinker | VALSPAR SOURCING, INC. | 2005-11-10 | — | — | US | claimed |
| EP-0847417-B1 | COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATES AND EPOXY COMPOUNDS | CYTEC TECH CORP (US) | 2004-11-24 | — | — | EP | claimed |
| EP-0792316-B1 | WATERBORNE COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATES | CYTEC TECH CORP (US) | 2004-06-16 | — | — | EP | claimed |
| EP-1242529-A1 | FORMALDEHYDE FREE 1,3,5-TRIAZINE CARBAMATE CROSSLINKERS AND CURABLE COMPOSITIONS CONTAINING SAME | CYTEC TECHNOLOGY CORP. (US) | 2002-09-25 | — | — | EP | claimed |
| WO-2001040368-A1 | FORMALDEHYDE FREE 1,3,5-TRIAZINE CARBAMATE CROSSLINKERS AND CURABLE COMPOSITIONS CONTAINING SAME | CYTEC TECHNOLOGY CORP. (US) | 2001-06-07 | — | — | WO | claimed |
| US-6204381-B1 | REACTING A 1,3,5-TRIAZINE DERIVATIVE WITH A (ISO)CYANATE COMPOUND | CYTEC TECHNOLOGY CORP. | 2001-03-20 | — | — | US | claimed |
| CN-1234814-A | Liquid cross-linker compositions containing 1,3,5-triazine carbamate/aminoplastic resin mixtures | CYTEC TECHNOLOGY CO LTD (US) | 1999-11-10 | — | — | CN | claimed |
| US-5852133-A | Curable compositions containing 1,3,5-triazine carbamates and epoxy compounds | CYTEC TECHNOLOGY CORP. (US) | 1998-12-22 | — | — | US | claimed |
| US-5714549-A | AQUEOUS MEDIUM HAVING HOMOGENEOUSLY DISPERSED THEREIN ACTIVE HYDROGEN-CONTAINING SURFACE ACTIVE RESIN, 1,3,5-TRIAZINE CARBAMATE CROSSLINKER | CYTEC TECHNOLOGY CORP. (US) | 1998-02-03 | — | — | US | claimed |
| US-5596047-A | CROSSLINKER FOR ACRYLIC COATINGS, AUTOMOTIVE FINISHES | CYTEC TECHNOLOGY CORP. (US) | 1997-01-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214949-A1 | TRIAZINE CARBAMATE CROSSLINKER | SCO2, CBR3, CBR1 | ACHE 382/4885HCAR2 1159/4885LDHA 4289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.